Mathers Edward T bought RYTM
March 12, 2026 · Form 4 insider transaction
Mathers Edward T bought 4,199 shares of Rhythm Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
NEA Partners 13, L.P. ("NEA Partners 13") made a pro rata distribution for no consideration of shares of Common Stock of the Issuer to its limited partners on March 12, 2026. The Edward Timothy Mathers Revocable Trust (the "Mathers Trust") received 4,199 shares of Common Stock of the Issuer in the distribution by NEA Partners 13 on March 12, 2026.; The Reporting Person is the trustee of the Mathers Trust, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by the Mathers Trust in which the Reporting Person has no pecuniary interest.